CFL2 p.Asp9del
c.24TGA[1] · rs1268123385 · VCV944237
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 5.1 | phastCons 1 |
| Overall | ||
| CADD | 21.6 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00133% | 74,938 |
| European (non-Finnish) | 8.47e-05% | 1,179,960 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CFL2
- Protein
- p.Asp9del
- Coding
- c.24TGA[1]
- MANE Select
- NM_138638
- dbSNP
- rs1268123385
- Type
- Microsatellite
- Location
- chr14:34713536 (GRCh38)
- Gene constraint
- LOEUF 0.91 · pLI 0.11 (gnomAD)
- Structure
- AlphaFold pLDDT 88.78 · 11 PDB
- Residue 9
- an α-helix; the adf-h domain; the 'interaction with csrp3' region
Disease context
nemaline myopathy 7 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Typical nemaline myopathy (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- Antenatal, Neonatal
- Prevalence
- 1-9 / 100 000 (Europe)
Similar variants
- CFL2 p.Asp9Ile Uncertain significance ★ same residue
- CFL2 p.Lys34fs Pathogenic ★★ same condition
- CFL2 p.Ser24del Uncertain significance ★★ same condition
- CFL2 p.Val159del Uncertain significance ★ same condition
- CFL2 c.4-12_4-11del Likely benign ★ same condition
- CFL2 c.4-172C>T Uncertain significance ★★ same condition
- CFL2 c.*1507C>T Uncertain significance ★★ same condition
- CFL2 c.*1759A>G Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfl2-p-asp9del (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown